juvenile RA
Etanercept, recombinant p75 sTNFR:Fc       fusion protein, has received approval from the US Food and Drug Administration       for patients with RA and juvenile RA (JRA) who have failed treatment with at       least one other drug.
Etanercept, recombinant p75 sTNFR:Fc       fusion protein, has received approval from the US Food and Drug Administration       for  @OBJECT$   @PREDICAT$  RA and  @SUBJECT$  (JRA) who have failed treatment with at       least one other drug.